.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Mallinckrodt
US Department of Justice
Dow
Healthtrust
Novartis
Johnson and Johnson
US Army
Harvard Business School
McKinsey

Generated: December 12, 2017

DrugPatentWatch Database Preview

Enoxacin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for enoxacin and what is the scope of enoxacin patent protection?

Enoxacin
is the generic ingredient in one branded drug marketed by Sanofi Aventis Us and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for enoxacin.

Medical Subject Heading (MeSH) Categories for enoxacin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis UsPENETREXenoxacinTABLET;ORAL019616-005Dec 31, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsPENETREXenoxacinTABLET;ORAL019616-004Dec 31, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: enoxacin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis UsPENETREXenoxacinTABLET;ORAL019616-004Dec 31, 1991► Subscribe► Subscribe
Sanofi Aventis UsPENETREXenoxacinTABLET;ORAL019616-005Dec 31, 1991► Subscribe► Subscribe
Sanofi Aventis UsPENETREXenoxacinTABLET;ORAL019616-005Dec 31, 1991► Subscribe► Subscribe
Sanofi Aventis UsPENETREXenoxacinTABLET;ORAL019616-005Dec 31, 1991► Subscribe► Subscribe
Sanofi Aventis UsPENETREXenoxacinTABLET;ORAL019616-004Dec 31, 1991► Subscribe► Subscribe
Sanofi Aventis UsPENETREXenoxacinTABLET;ORAL019616-004Dec 31, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Cantor Fitzgerald
QuintilesIMS
Citi
Medtronic
Mallinckrodt
Boehringer Ingelheim
Covington
Fish and Richardson
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot